Literature DB >> 8480582

Increased risk of progressive hemodynamic deterioration in advanced heart failure patients requiring permanent pacemakers.

L A Saxon1, W G Stevenson, H R Middlekauff, L W Stevenson.   

Abstract

To determine the influence of long-term permanent pacing systems on survival in patients with severe left ventricular dysfunction, data from 557 consecutive patients hospitalized with advanced heart failure for cardiac transplant evaluation and discharged on medical therapy were reviewed. Permanent pacemakers were identified in 42 (8%) patients. One-year actuarial risk of death from heart failure or urgent transplantation in paced patients was higher (49%) than that of a control group, matched for the severity of heart failure (15%, p = 0.003). Sudden death did not differ between paced patients and controls.

Entities:  

Mesh:

Year:  1993        PMID: 8480582     DOI: 10.1016/0002-8703(93)90999-p

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  12 in total

1.  The DAVID trial and its implications: where do we go from here?

Authors:  Brian Olshansky
Journal:  Curr Cardiol Rep       Date:  2003-09       Impact factor: 2.931

2.  Characteristics of the electrocardiogram in patients with continuous-flow left ventricular assist devices.

Authors:  Sara C Martinez; Derrick Fansler; Jeffrey Lau; Eric L Novak; Susan M Joseph; Robert E Kleiger
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-07-07       Impact factor: 1.468

Review 3.  Gene therapy to restore electrophysiological function in heart failure.

Authors:  Lukas J Motloch; Fadi G Akar
Journal:  Expert Opin Biol Ther       Date:  2015-04-12       Impact factor: 4.388

4.  Permanent direct His bundle pacing: initial report showing technical feasibility of an alternative pacing therapy.

Authors:  J H Geertman; P P Delnoy; H A Oude Luttikhuis
Journal:  Neth Heart J       Date:  2002-02       Impact factor: 2.380

5.  Innovation focus: the patient with arrhythmia.

Authors:  Samuel J Asirvatham
Journal:  J Cardiovasc Transl Res       Date:  2008-09-30       Impact factor: 4.132

6.  Chronic kidney disease and mortality in implantable cardioverter-defibrillator recipients.

Authors:  Aamir Cheema; Tejwant Singh; Manreet Kanwar; Karuna Chilukuri; Viqar Maria; Fareena Saleem; Katrina Johnson; John Frank; Luis Pires; Sohail Hassan
Journal:  Cardiol Res Pract       Date:  2010-08-03       Impact factor: 1.866

7.  Calmodulin kinase II is required for fight or flight sinoatrial node physiology.

Authors:  Yuejin Wu; Zhan Gao; Biyi Chen; Olha M Koval; Madhu V Singh; Xiaoqun Guan; Thomas J Hund; William Kutschke; Satyam Sarma; Isabella M Grumbach; Xander H T Wehrens; Peter J Mohler; Long-Sheng Song; Mark E Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-10       Impact factor: 11.205

8.  A randomized comparison of defibrillation thresholds in the right ventricular outflow tract versus right ventricular apex.

Authors:  Michael Mollerus; Margaret Lipinski; Thomas Munger
Journal:  J Interv Card Electrophysiol       Date:  2008-05-10       Impact factor: 1.900

9.  Medium- and long-term survival after pacemaker implant: Improved survival with right ventricular outflow tract pacing.

Authors:  Gabriel Vanerio; Juan L Vidal; Pablo Fernández Banizi; Daniel Banina Aguerre; Pablo Viana; Jorge Tejada
Journal:  J Interv Card Electrophysiol       Date:  2008-03-07       Impact factor: 1.900

10.  Cardiac resynchronization therapy in heart failure: recent advances and new insights.

Authors:  V Bhatia; R Bhatia; S Dhindsa; A Virk
Journal:  Indian Pacing Electrophysiol J       Date:  2003-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.